Molecular evidence for the role of mycobacteria in sarcoidosis: A meta-analysis

European Respiratory Journal

Volumn 30, Issue 3, 2007, Pages 508-516

  Gupta, D ^a   Agarwal, R ^a   Aggarwal, A N ^a   Jindal, S K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Mycobacteria; Polymerase chain reaction; Sarcoidosis; Tuberculosis

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; CINAHL; CLINICAL TRIAL; CONFIDENCE INTERVAL; EMBASE; HUMAN; MEDLINE; META ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUBLISHING; RISK; SARCOIDOSIS; SYSTEMATIC REVIEW; COMPUTER PROGRAM; GENETICS; MICROBIOLOGY; MYCOBACTERIOSIS; MYCOBACTERIUM; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION;

HUMANS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; SARCOIDOSIS, PULMONARY; SELF-SUSTAINED SEQUENCE REPLICATION; SOFTWARE DESIGN;

EID: 38449083335     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00002607     Document Type: Article

References (77)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
2. Perez RL, Rivera-Marrero CA, Roman J. Pulmonary granulomatous inflammation: from sarcoidosis to tuberculosis. Semin Respir Infect 2003; 18: 23-32.
3. Newman LS. Aetiologies of sarcoidosis. In: Dent M, Costabel U, eds. Sarcoidosis. Eur Respir Mon 2005; 32: 23-48.
4. Thomeer M, Demedts M, Wuyts W. Epidemiology of sarcoidosis. In: Dent M, Costabel U, eds. Sarcoidosis. Eur Respir Mon 2005; 32: 13-22.
5. du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med 2003; 253: 4-17.
6. Drake WP, Newman LS. Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med 2006; 12: 359-363.
7. Ishige I, Eishi Y, Takemura T, et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 33-42.
8. Sharma OP. Murray Kornfeld, American College Of Chest Physician, and sarcoidosis: a historical footnote: 2004 Murray Kornfeld Memorial Founders Lecture. Chest 2005; 128: 1830-1835.
9. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992; 327: 293-301.
10. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953-1966.
11. Armitage P, Berry G, Matthews JNS. Analysing means and proportions. Statistical Methods in Medical Research. 4th Edn. Oxford, Blackwell Science, 2002; pp. 83-146.
12. Newcombe R. Two-sided confidence intervals for the single proportion: a comparative evaluation of seven methods. Stat Med 1998; 17: 857-872.
13. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies. Respir Med 2006; 100: 2043-2047.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
15. Martin DO, Austin H. An exact method for meta-analysis of case-control and follow-up studies. Epidemiology 2000; 11: 255-260.
16. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986; 7: 267-275.
17. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-826.
18. Dear K, Begg C. An approach to assessing publication bias prior to performing a meta-analysis. Stat Sci 1992; 7: 237-245.
19. Liedtke W, May A, Dux R, Faustmann PM, Zimmermann CW. Mycobacterium tuberculosis polymerase chain reaction findings in neurosarcoidosis. J Neurol Sci 1993; 120: 118-119.
20. Eguchi T, Kobayashi M, Miyoshi I. Mycobacterial DNA was detected in a intramuscular sarcoid granuloma by the polymerase chain reaction - a case report. Jap J Chest Dis 1994; 53: 848-852.
21. Schick U, May A, Schwarz M. Detection of mycobacterial DNA in a patient with neurosarcoidosis. Acta Neurol Scand 1995; 91: 280-282.
22. Baselga E, Barnadas MA, Margall N, de Moragas JM. Detection of M. tuberculosis complex: DNA in a lesion resembling sarcoidosis. Clin Exp Dermatol 1996; 21: 235-238.
23. el-Zaatari FA, Graham DY, Samuelsson K, Engstrand L. Detection of Mycobacterium avium complex in cerebrospinal fluid of a sarcoid patient by specific polymerase chain reaction assays. Scand J Infect Dis 1997; 29: 202-204.
24. Wong CF, Yew WW, Wong PC, Lee J. A case of concomitant tuberculosis and sarcoidosis with mycobacterial DNA present in the sarcoid lesion. Chest 1998; 114: 626-629.
25. Moling O, Sechi LA, Zanetti S, et al. Mycobacterium marinum, a further infectious agent associated with sarcoidosis: the polyetiology hypothesis. Scand J Infect Dis 2006; 38: 148-152.
26. Bohle RM, Heidemann A, Borkhardt A, Velcovsky HG, Altmannsberger HM. [Detection of mycobacterial DNA from paraffin-embedded tissue in lung and lymphoid epithelial granulomas.] Verh Dtsch Ges Pathol 1994; 78: 189-194.
27. Gazouli M, Ikonomopoulos J, Koundourakis A, et al. Characterization of Mycobacterium tuberculosis complex isolates from Greek patients with sarcoidosis by spoligotyping. J Clin Microbiol 2005; 43: 4858-4861.
28. Bocart D, Lecossier D, De Lassence A, Valeyre D, Battesti JP, Hance AJ. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992; 145: 1142-1148.
29. Gerdes J, Richter E, Rusch-Gerdes S, et al. Mycobacterial nucleic acids in sarcoid lesions. Lancet 1992; 339: 1536-1537.
30. Mitchell IC, Turk JL, Mitchell DN. Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet 1992; 339: 1015-1017.
31. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339: 1012-1015.
32. Thakker B, Black M, Foulis AK. Mycobacterial nucleic acids in sarcoid lesions. Lancet 1992; 339: 1537.
33. Fidler HM, Rook GA, Johnson NM, McFadden J. Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ 1993; 306: 546-549.
34. Lisby G, Milman N, Jacobsen GK. Search for Mycobacterium paratuberculosis DNA in tissue from patients with sarcoidosis by enzymatic gene amplification. Apmis 1993; 101: 876-878.
35. Ghossein RA, Ross DG, Salomon RN, Rabson AR. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction. Am J Clin Pathol 1994; 101: 733-737.
36. Popper HH, Winter E, Hofler G. DNA of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction. Am J Clin Pathol 1994; 101: 738-741.
37. el-Zaatari FA, Naser SA, Markesich DC, Kalter DC, Engstand L, Graham DY. Identification of Mycobacterium avium complex in sarcoidosis. J Clin Microbiol 1996; 34: 2240-2245.
38. Richter E, Greinert U, Kirsten D, et al. Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med 1996; 153: 375-380.
39. Cannone M, Vago L, Porini G, et al. [Detection of Mycobacterium tuberculosis DNA using nested polymerase chain reaction in lymph nodes with sarcoidosis, fixed in formalin and embedded in paraffin.] Pathologica 1997; 89: 512-516.
40. Ozcelik U, Ozkara HA, Gocmen A, et al. Detection of Mycobacterium tuberculosis DNA in tissue samples of children with sarcoidosis. Pediatr Pulmonol 1997; 24: 122-124.
41. Popper HH, Klemen H, Hoefler G, Winter E. Presence of mycobacterial DNA in sarcoidosis. Hum Pathol 1997; 28: 796-800.
42. Vokurka M, Lecossier D, du Bois RM, et al. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1000-1003.
43. Vago L, Barberis M, Gori A, et al. Nested polymerase chain reaction for Mycobacterium tuberculosis IS6110 sequence on formalin-fixed paraffin-embedded tissues with granulomatous diseases for rapid diagnosis of tuberculosis. Am J Clin Pathol 1998; 109: 411-415.
44. Wilsher ML, Menzies RE, Croxson MC. Mycobacterium tuberculosis DNA in tissues affected by sarcoidosis. Thorax 1998; 53: 871-874.
45. Grosser M, Luther T, Muller J, et al. Detection of M. tuberculosis DNA in sarcoidosis: correlation with T-cell response. Lab Invest 1999; 79: 775-784.
46. Ikonomopoulos JA, Gorgoulis VG, Zacharatos PV, et al. Multiplex polymerase chain reaction for the detection of mycobacterial DNA in cases of tuberculosis and sarcoidosis. Mod Pathol 1999; 12: 854-862.
47. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999; 354: 120-123.
48. Li N, Bajoghli A, Kubba A, Bhawan J. Identification of mycobacterial DNA in cutaneous lesions of sarcoidosis. J Cutan Pathol 1999; 26: 271-278.
49. Ikonomopoulos JA, Gorgoulis VG, Kastrinakis NG, et al. Sensitive differential detection of genetically related mycobacterial pathogens in archival material. Am J Clin Pathol 2000; 114: 940-950.
50. Klemen H, Husain AN, Cagle PT, Garrity ER, Popper HH. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung - a PCR-based study on four cases. Virchows Arch 2000; 436: 365-369.
51. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 2002; 8: 1334-1341.
52. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002; 40: 198-204.
53. Gazouli M, Ikonomopoulos J, Trigidou R, Foteinou M, Kittas C, Gorgoulis V. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of Greek patients with sarcoidosis. J Clin Microbiol 2002; 40: 3060-3063.
54. Milman N, Lisby G, Friis S, Kemp L. Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. A negative study. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 25-28.
55. Grosser M, Luther T, Fuessel M, Bickhardt J, Magdolen V, Baretton G. Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 66-74.
56. Marcoval J, Benitez MA, Alcaide F, Mana J. Absence of ribosomal RNA of Mycobacterium tuberculosis complex in sarcoidosis. Arch Dermatol 2005; 141: 57-59.
57. Dubaniewicz A, Dubaniewicz-Wybieralska M, Sternau A, et al. Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J Clin Microbiol 2006; 44: 3448-3451.
58. Fite E, Fernandez-Figueras MT, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 2006; 73: 20-26.
59. Kent DC, Houk VN, Elliott RC, Sokolowski JW Jr, Baker JH, Sorensen K. The definitive evaluation of sarcoidosis. Am Rev Respir Dis 1970; 101: 721-727.
60. Hatzakis K, Siafakas NM, Bouros D. Miliary sarcoidosis following miliary tuberculosis. Respiration 2000; 67: 219-222.
61. Vanek J, Schwarz J. Demonstration of acid-fast rods in sarcoidosis. Am Rev Respir Dis 1970; 101: 395-400.
62. Cantwell AR Jr. Variably acid-fast bacteria in a case of systemic sarcoidosis and hypodermitis sclerodermiformis. Dermatologica 1981; 163: 239-248.
63. Cantwell AR Jr. Histologic observations of variably acid-fast pleomorphic bacteria in systemic sarcoidosis: a report of 3 cases. Growth 1982; 46: 113-125.
64. Mitchell DN, Rees RJ. A transmissible agent from sarcoid tissue. Lancet 1969; 2: 81-84.
65. Mitchell DN, Rees RJ. An attempt to demonstrate a transmissible agent from sarcoid material. Postgrad Med J 1970; 46: 510-514.
66. Mitchell DN, Rees RJ, Goswami KK. Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet 1976; 2: 761-765.
67. Mitchell DN. The nature and physical characteristics of a transmissible agent from human sarcoid tissue. Ann NY Acad Sci 1976; 278: 233-248.
68. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005; 201: 755-767.
69. Almenoff PL, Johnson A, Lesser M, Mattman LH. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996; 51: 530-533.
70. Schoedon G, Goldenberger D, Forrer R, et al. Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J Infect Dis 1997; 176: 672-677.
71. Edelson E. Isoniazid in the treatment of sarcoidosis; a preliminary report. J Invest Dermatol 1953; 21: 71-74.
72. Israel HL, Sones M, Harrell D. Ineffectiveness of isoniazid and iproniazid in therapy of sarcoidosis. Am Rev Tuberc 1953; 67: 671-673.
73. Holsinger RE, Dalton JE. Isoniazid therapy in cutaneous tuberculosis and sarcoidosis. J Am Med Assoc 1954; 154: 475-481.
74. Hoyle C, Dawson J, Mather G. Treatment of pulmonary sarcoidosis with streptomycin and cortisone. Lancet 1955; 268: 638-643.
75. Chatterjee SC, Ghosh JC. Sarcoidosis treated with antituberculous drugs. J Indian Med Assoc 1957; 29: 61-63.
76. James DG, Thomson AD. The course of sarcoidosis and its modification by treatment. Lancet 1959; 1: 1057-1061.
77. Mangiapan G, Hance AJ. Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Sarcoidosis 1995; 12: 20-37.